Table 7.

Clinical chemistry of female rats treated with GlucoMedix® at 28 days

Group/dose (mg/kg)	GLU (mg/dL)	T-Chol (mg/dL)	TG (mg/dL)	AST (U/L)	ALT (U/L)	BUN (mg/dL)	Crea (mg/dL)	TSH (mIU/L)	T3 (mIU/L)	T4 (ug/dL)
250	90.6 + 3.36	94.0 + 1.58	68.0 + 2.35	30.8 + 1.30	33.2 + 0.84	39.4 + 1.67	0.74 + 0.15	2.90 + 0.33	2.68 + 0.08	1.00 + 0.19
1000	87.0 + 2.74	95.2 + 1.92	64.6 + 1.67	29.8 + 1.30	31.6 + 2.07	37.0 + 1.58	0.7 + 0.16	2.76 + 0.38	2.54 + 0.23	0.90 + 0.27
2000	85.8 + 3.19	89.2 + 1.64	64.0 + 1.58	25.0 + 2.55	31.2 + 1.30	32.6 + 2.19	0.72 + 0.18	2.96 + 0.44	2.28 + 0.24	0.84 + 0.18
Control	85.0 + 4.18	90.2 + 4.82	62.8 + 1.92	25.6 + 2.70	34.6 + 3.36	33.6 + 2.61	0.7 + 0.14	2.80 + 0.30	2.32 + 0.28	0.90 + 0.12

Values are expressed as mean ± SD. n = 5. Parameters included: glucose (GLU), total cholesterol (T-Chol), triglycerides (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), creatinine (Crea), thyroid stimulating hormone (TSH), and thyroid hormones (T3, T4). No significant difference between the parameters compared to the control group